Table of Contents
ISRN Ophthalmology
Volume 2011 (2011), Article ID 465198, 6 pages
http://dx.doi.org/10.5402/2011/465198
Clinical Study

Meibomian Gland Dysfunction: Endocrine Aspects

1Department of Ophthalmology, College of Health Sciences, Middle East Technical University, 06800 Ankara, Turkey
2Department of Statistics, Middle East Technical University, 06800 Ankara, Turkey
3Department of Biochemistry, College of Health Sciences, Middle East Technical University, 06800 Ankara, Turkey

Received 15 July 2011; Accepted 21 August 2011

Academic Editor: J. Wang

Copyright © 2011 Ozlem G. Sahin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Knop, N. Knop, H. Brewitt et al., “Meibomian glands: part III. Dysfuction- argument for a discrete disease entity and as an important cause of dry eye,” Ophthalmologe, vol. 106, no. 11, pp. 966–979, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. E. Knop and N. Knop, “Meibomian glands: part IV. Functional interactions in the pathogenesis of meibomian gland dysfunction (MGD),” Ophthalmologe, vol. 106, no. 11, pp. 980–987, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. R. Arita, K. Itoh, S. Maeda et al., “Proposed diagnostic criteria for seborrheic meibomian gland dysfunction,” Cornea, vol. 29, no. 9, pp. 980–984, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. K. L. Krenzer, M. R. Dana, M. D. Ullman et al., “Effect of androgen deficiency on the human meibomian gland and ocular surface,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 12, pp. 4874–4882, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. D. A. Sullivan, B. D. Sullivan, J. E. Evans et al., “Androgen deficiency, meibomian gland dysfunction, and evaporative dry eye,” Annals of the New York Academy of Sciences, vol. 966, pp. 211–222, 2002. View at Google Scholar · View at Scopus
  6. J. Shimazaki, M. Sakala, and K. Tsubota, “Ocular surface changes and discomfort in patients with meibomian gland dysfunction,” Archives of Ophthalmology, vol. 113, no. 10, pp. 1266–1270, 1995. View at Google Scholar · View at Scopus
  7. W. D. Mathers, W. J. Shields, M. S. Sachdev, W. M. Petroll, and J. V. Jester, “Meibomian gland dysfunction in chronic blepharitis,” Cornea, vol. 10, no. 4, pp. 277–285, 1991. View at Google Scholar · View at Scopus
  8. J. Shimazaki and K. Tsubota, “Evaluation of meibomian gland dysfunction via meibography,” Atarashii-Ganka, vol. 10, pp. 1031–1034, 1993. View at Google Scholar
  9. J. Shimazaki, E. Goto, M. Ono, S. Shimmura, and K. Tsubota, “Meibomian gland dysfunction in patients with Sjögren syndrome,” Ophthalmology, vol. 105, no. 8, pp. 1485–1488, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Arita, K. Itoh, S. Maeda et al., “Efficiancy and diagnostic criteria for the differential diagnosis between obstructive meibomian gland dysfunction and aqeous deficiency dry eye,” Japanese Journal of Ophthalmology, vol. 54, pp. 387–391, 2010. View at Google Scholar
  11. D. A. Sullivian, B. D. Sullivian, M. D. Ullman et al., “Androgen influence on the meibomian gland,” Investigative Ophthalmology & Visual Science, vol. 41, pp. 3732–3742, 2000. View at Google Scholar
  12. M. Placzek, B. Arnold, H. Schmidt et al., “Elevated 17-hydroxyprogesterone serum values in male patients with acne,” Journal of the American Academy of Dermatology, vol. 53, no. 6, pp. 955–958, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. C. C. Zouboulis, W. C. Chen, M. J. Thornton, K. Qin, and R. Rosenfield, “Sexual hormones in human skin,” Hormone and Metabolic Research, vol. 39, no. 2, pp. 85–95, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. F. Labrie, A. Belanger, V. Luu-The et al., “DHEA and intracrine formation of androgens and estrogens in peripheral target tissues: its role during aginig,” Steroids, vol. 63, no. 5-6, pp. 322–328, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. B. J. Kim, J. Y. Kim, H. C. Eun, O. S. Kwon, M. N. Kim, and B. I. Ro, “Androgenic alopecia in adolescents: a report of 43 cases,” Journal of Dermatology, vol. 33, no. 10, pp. 696–699, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. F. Vitale and P. Ruggieri, “LHRH analogues and PCO disease: validity of the use of enantone depot in the treatment of the disease,” Acta Europaea Fertilitatis, vol. 23, no. 6, pp. 293–295, 1992. View at Google Scholar · View at Scopus
  17. U. Cirkel, L. Belkien, J. P. Hanker, K. W. Schweppe, and H. P. Schneider, “Effects of a chlormadione acetate-containing ovulation inhibitor on androgenization pictures and liver and lipid metabolism in young females,” Geburtshilfe Frauenheilkd, vol. 46, pp. 439–443, 1986. View at Google Scholar
  18. F. Labrie, “DHEA, important source of sex steroids in men and even more in women,” Progress in Brain Research, vol. 182, pp. 97–148, 2010. View at Google Scholar · View at Scopus
  19. C. C. Zouboulis, “The sebaceous gland,” Hautarzt, vol. 61, no. 6, pp. 467–477, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. C. C. Zouboulis, “Acne and sebaceous gland function,” Clinics in Dermatology, vol. 22, no. 5, pp. 360–366, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. W. D. Mathers, D. Stovall, J. A. Lane, M. B. Zimmerman, and S. Johnson, “Menopause and tear function: the influence of prolactin and sex hormones on human tear production,” Cornea, vol. 17, no. 4, pp. 353–358, 1998. View at Publisher · View at Google Scholar · View at Scopus